Mohammed A. Rafi

Mohammed A. Rafi,

Contact Dr. Rafi

1020 Locust Street
Suite 393 JAH
Philadelphia, PA 19107

(215) 503-5715
(215) 923-7747 fax

Most Recent Peer-reviewed Publications

  1. Recent advances in targeted delivery of tissue plasminogen activator for enhanced thrombolysis in ischaemic stroke
  2. Spectrophotometric analysis of thrombolytic activity: SATA assay
  3. Debate on human aging and lifespan
  4. Krabbe disease: One Hundred years from the bedside to the bench to the bedside
  5. Gene therapy for CNS diseases - Krabbe disease
  6. Blood-brain barrier transport machineries and targeted therapy of brain diseases
  7. Long-term improvements in lifespan and pathology in CNS and PNS after BMT plus one intravenous injection of AAVrh10-GALC in twitcher mice
  8. To impact or not to impact, this is not a question for BioImpacts!
  9. A prospective highlight on exosomal nanoshuttles and cancer immunotherapy and vaccination
  10. Intravenous injection of AAVrh10-GALC after the neonatal period in twitcher mice results in significant expression in the central and peripheral nervous systems and improvement of clinical features
  11. Krabbe disease: Are certain mutations disease-causing only when specific polymorphisms are present or when inherited in trans with specific second mutations?
  12. Lysosomal storage diseases: Heterogeneous group of disorders
  13. Sixteen novel mutations in the arylsulfatase A gene causing metachromatic leukodystrophy
  14. Extended normal life after AAVrh10-mediated gene therapy in the mouse model of krabbe disease
  15. Gene and stem cell therapy: Alone or in combination?
  16. Combined effects of hyperglycemic conditions and HIV-1 Nef: A potential model for induced HIV neuropathogenesis
  17. Effects of treatments on inflammatory and apoptotic markers in the CNS of mice with globoid cell leukodystrophy
  18. Significant correction of pathology in brains of twitcher mice following injection of genetically modified mouse neural progenitor cells
  19. HIV-1 Vpr potently induces programmed cell death in the CNS in vivo
  20. A single mutation in the GALC gene is responsible for the majority of late onset Krabbe disease patients in the Catania (Sicily, Italy) region.